FDA Quietly Approves Denosumab Biosimilars, Issues Interchangeability for Others
On Nov. 13, 2025, the U.S. Food and Drug Administration (FDA) approved multiple denosumab biosimilars, enhancing market access…
On Nov. 13, 2025, the U.S. Food and Drug Administration (FDA) approved multiple denosumab biosimilars, enhancing market access…
On Nov. 12, 2025, a study led by the Hebrew University of Jerusalem, and the Laboratory of Entomology…
On Nov. 12, 2025, Allen Institute researchers and engineers have unlocked an the world’s most comprehensive AI-powered tool…
On Nov. 12, 2025, a team of University of California, Berkeley-led researchers reported in Nano Letters that they…
On Nov. 12, 2025, Stanford Medicine scientists have found that the Epstein-Barr virus can convert B cells it’s…
On Nov. 12, 2025, UK researchers reported a test-negative, case-control study across 14 hospitals in England finds that the…
On Nov. 11, 2025, the United Kingdom government announced that animal testing in science is set to be…
On Nov. 11, 2025, China introduced a visa that will allow young foreign researchers in science, technology, engineering…
On Nov. 10, 2025, a study led by the University of Liverpool reported that existing evidence does not…
On Nov. 10, 2025, Canada has lost its measles elimination status after nearly three decades due to its…
On Nov. 9, 2025, scientists from the Center for Marine Environmental Sciences, University of Bremen reported they had…
On Nov. 7, 2025, research published today in Cell Reports Medicine reveals key biological differences that may explain why…
On Nov. 6, 2025, the Institute for Health Metrics and Evaluation (IHME) at the University of Washington School…
On Nov. 6, 2025, Eli Lilly announced an agreement with the U.S. government to expand access to its…
On Nov. 6, 2025, scientists from Oxford’s Radcliffe Department of Medicine have achieved the most detailed view yet…
On Nov. 6, 2025, Novo Nordisk announced it has agreed with the U.S. Administration to lower drug prices…
On Nov. 5, 2025, a large study of adults with type 2 diabetes showed that those who consistently…
On Nov. 5, 2025, an Osaka Metropolitan University team has used stem cells extracted from adipose, the body’s…
On Nov. 5, 2025, MIT researchers announced they have developed a new 3D human brain tissue platform, the…
On Nov. 5, 2025, the World Health Organization (WHO) reported that between 20 September and 30 October 2025,…
On Nov. 4, 2025, Colossal Biosciences, the world’s de-extinction company, announced its acquisition of Viagen Pets and Equine,…
On Nov. 4, 2025, six years ago this month, scientists launched a massively ambitious effort to sequence the…
On Nov. 4, 2025, the U.S. Food and Drug Administration (FDA) approved revumenib, a first-in-class oral menin inhibitor,…
On Nov. 3, 2025, United Therapeutics, a public benefit corporation, announced the first clinical xenotransplantation in its EXPAND…
On Nov. 3, 2025, scientists at the University of California, San Diego (UC San Diego) announced they have…
On Oct. 31, 2025, investigators from Mass General Brigham, the Broad Institute of MIT and Harvard, and VA…
On Oct. 30, 2025, the California Institute for Regenerative Medicine (CIRM) approved awarding $27 million through three grants…
On Oct. 30, 2025, researchers at Virginia Commonwealth University and VCU Health announced preliminary study findings that show…
On Oct. 29, 2025, the Alice L. Walton School of Medicine (AWSOM) celebrated its grand opening on the…
On Oct. 29, 2025, Thermo Fisher announced it would buy privately held data management company Clario for up…